Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda
dc.contributor.author | Bakanda, Celestin | |
dc.contributor.author | Birungi, Josephine | |
dc.contributor.author | Mwesigwa, Robert | |
dc.contributor.author | Nachega, Jean B. | |
dc.contributor.author | Chan, Keith | |
dc.contributor.author | Palmer, Alexis | |
dc.contributor.author | Ford, Nathan | |
dc.contributor.author | Mills, Edward J. | |
dc.date.accessioned | 2022-02-04T11:48:00Z | |
dc.date.available | 2022-02-04T11:48:00Z | |
dc.date.issued | 2011 | |
dc.description.abstract | Adolescents have been identified as a high-risk group for poor adherence to and defaulting from combination antiretroviral therapy (cART) care. However, data on outcomes for adolescents on cART in resource-limited settings remain scarce. Methods: We developed an observational study of patients who started cART at The AIDS Service Organization (TASO) in Uganda between 2004 and 2009. Age was stratified into three groups: children (#10 years), adolescents (11–19 years), and adults ($20 years). Kaplan-Meier survival curves were generated to describe time to mortality and loss to follow-up, and Cox regression used to model associations between age and mortality and loss to follow-up. To address loss to follow up, we applied a weighted analysis that assumes 50% of lost patients had died. Findings: A total of 23,367 patients were included in this analysis, including 810 (3.5%) children, 575 (2.5%) adolescents, and 21 982 (94.0%) adults. A lower percentage of children (5.4%) died during their cART treatment compared to adolescents (8.5%) and adults (10%). After adjusting for confounding, other features predicted mortality than age alone. Mortality was higher among males (p,0.001), patients with a low initial CD4 cell count (p,0.001), patients with advanced WHO clinical disease stage (p,0.001), and shorter duration of time receiving cART (p,0.001). The crude mortality rate was lower for children (22.8 per 1000 person-years; 95% CI: 16.1, 29.5), than adolescents (36.5 per 1000 person-years; 95% CI: 26.3, 46.8) and adults (37.5 per 1000 person-years; 95% CI: 35.9, 39.1). | en_US |
dc.identifier.citation | Bakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, et al. (2011) Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda. PLoS ONE 6(4): e19261. doi:10.1371/journal.pone.0019261 | en_US |
dc.identifier.other | 10.1371/journal.pone.0019261 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1884 | |
dc.language.iso | en | en_US |
dc.publisher | PLoS ONE | en_US |
dc.subject | HIV-Infected Adolescents | en_US |
dc.subject | Antiretroviral Therapy | en_US |
dc.subject | Uganda | en_US |
dc.subject | Nationally Representative Cohort | en_US |
dc.title | Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Survival of HIV-Infected Adolescents on Antiretroviral.pdf
- Size:
- 189.32 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: